When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Progressive multifocal leukoencephalopathy - Wikipedia

   en.wikipedia.org/wiki/Progressive_multifocal...

   Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal viral disease characterized by progressive damage (-pathy) or inflammation of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal). It is caused by the JC virus, which is normally present and kept under control by the immune system. The ...

3. Toxic leukoencephalopathy - Wikipedia

   en.wikipedia.org/wiki/Toxic_leukoencephalopathy

   Toxic leukoencephalopathy is a rare condition that is characterized by progressive damage (-pathy) to white matter (-leuko-) in the brain (-encephalo-), particularly myelin, due to causes such as exposure to substance use, environmental toxins, or chemotherapeutic drugs. The prevalence of this disease is infrequent and often goes unreported ...

4. Leukoencephalopathy - Wikipedia

   en.wikipedia.org/wiki/Leukoencephalopathy

   A CT of leukoencephalopathy. Leukoencephalopathy (leukodystrophy-like diseases) is a term that describes all of the brain white matter diseases, whether their molecular cause is known or unknown. [1] It can refer specifically to any of these diseases: Progressive multifocal leukoencephalopathy; Toxic leukoencephalopathy

5. Human polyomavirus 2 - Wikipedia

   en.wikipedia.org/wiki/Human_polyomavirus_2

   The boxed warning was added on February 19, 2009, for the drug efalizumab (Raptiva) includes a statement that Human polyomavirus 2, resulting in progressive multifocal leukoencephalopathy, developed in three patients who received efalizumab in clinical trials. The drug was pulled off the U.S. market because of the association with PML on April ...

6. Natalizumab - Wikipedia

   en.wikipedia.org/wiki/Natalizumab

   While none of them had taken the drug in combination with other disease-modifying treatments, previous use of MS treatments increases the risk of PML between 3 and 4-fold. [26] In 2016, EMA recommended all people taking natalizumab should undergo full MRI scans at least once a year due to concerns of progressive multifocal leukoencephalopathy ...

7. Memory loss isn’t always Alzheimer’s: Experts warn of common ...

   www.aol.com/memory-loss-isn-t-always-230026157.html

   As Alzheimer’s disease is the most common form of dementia — affecting an estimated 6.7 million Americans — it’s not surprising that people who experience memory loss may suspect AD.. In ...